دارو جابرابن حیان

دجابر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 57,940 3.00
Close Price: 57,940

Financial Ratios

2026/04/19
Fiscal Year 2025/12/2112 Month
2025/02/18
Fiscal Year 2024/12/2012 Month
2024/03/16
Fiscal Year 2023/12/2112 Month

Net Profit to Sales

8.9365.6715.21

Gross Profit to Sales

9.1165.6717.01

Operating Margin

12.187.1117.71

Gross Profit to Sales

29.9620.1827.05

Net Profit to Gross Profit

29.81325.4756.24

Return on Assets (ROA)

5.4131.548.16

Return on Capital (%)

62.72364.9371.33

Return on Equity (ROE)

12.0559.5523.94

Working Capital Return

13.267.0336.43

Fixed Asset Return

77.55426.2687.89

Loan Benefit Assessment

2.231.892.93

Current Ratio

1.832.081.35

Quick Ratio

1.631.891.22

Liquidity Ratio

0.040.450.03

Net Working Capital

10,777,45712,348,2224,440,262

Current Assets Ratio

0.910.910.86

Inventory Turnover

77.2670.0690.47

Receivables Collection Period

432.93460.63451.18

Inventory to Working Capital

0.240.170.38

Working Capital Turnover

1.481.022.4

Fixed Asset Turnover

8.686.495.78

Total Asset Turnover

0.610.480.54

Debt Ratio

0.550.470.66

Debt to Equity

1.230.891.93

Long-Term Debt to Equity

0.120.070.07

Current Debt to Equity

1.10.821.86

Equity Ratio

44.9152.9734.08

Debt Coverage Ratio

1.262.083.9